Trust Point Inc. Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Trust Point Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,262 shares of the medical equipment provider’s stock after buying an additional 162 shares during the period. Trust Point Inc.’s holdings in Intuitive Surgical were worth $1,181,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. Alliance Wealth Advisors LLC UT purchased a new position in Intuitive Surgical during the fourth quarter worth about $278,000. Optas LLC raised its holdings in Intuitive Surgical by 22.1% during the fourth quarter. Optas LLC now owns 795 shares of the medical equipment provider’s stock worth $415,000 after purchasing an additional 144 shares in the last quarter. Financial Life Planners acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $81,000. Prudent Investors Network Inc. purchased a new position in Intuitive Surgical in the 4th quarter valued at $290,000. Finally, Catalina Capital Group LLC grew its position in Intuitive Surgical by 1.7% in the 4th quarter. Catalina Capital Group LLC now owns 2,714 shares of the medical equipment provider’s stock valued at $1,417,000 after buying an additional 46 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Truist Financial boosted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Leerink Partners increased their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Raymond James raised their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,843 shares of company stock valued at $15,357,560. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $578.55 on Tuesday. The company has a market capitalization of $206.07 billion, a price-to-earnings ratio of 90.26, a P/E/G ratio of 5.51 and a beta of 1.39. The business’s 50-day moving average is $550.40 and its 200-day moving average is $510.02. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.